Name of Biosimilar | Manufacturer | Status |
---|---|---|
MYL-1701P | Momenta Pharmaceuticals and Mylan NV, USA | Phase 3 trial completed |
ABP-938 | Amgen, USA | Phase 3 trial active; recruitment stage |
FYB203 | Formycon AG/Bioeq, Germany | Phase 3 trial active; recruitment stage |
SB-15 | Samsung Bioepis Co. Ltd, South Korea | Phase 3 trial active; recruitment stage |
SOK583A19 | Sandoz, Switzerland | Phase 3 trial active; recruitment stage |
CT-P42 | Celltrion, South Korea | Phase 3 trial active; recruitment stage |
ALT-L9 | Alteogen, South Korea | Phase 1 trial begun; not yet recruiting |
OT-702 | Ocumension Therapeutics/Shandong Boan Biological Technology, China | Phase 3 trial active |